BIPIX Holdings — Biotechnology
All 146 reported holdings of Biotechnology (BIPIX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Agpxx | 2.05% | $3.75M |
| Apellis Pharmaceuticals, Inc. | 1.35% | $2.46M |
| Revolution Medicines, Inc. | 1.19% | $2.17M |
| Travere Therapeutics, Inc. | 1.17% | $2.14M |
| Arrowhead Pharmaceuticals, Inc. | 1.04% | $1.90M |
| Twist Bioscience Corp. | 1.03% | $1.87M |
| Summit Therapeutics, Inc. | 1.01% | $1.85M |
| Alkermes PLC | 1.00% | $1.82M |
| Tg Therapeutics, Inc. | 0.99% | $1.81M |
| Madrigal Pharmaceuticals, Inc. | 0.99% | $1.80M |
| Beam Therapeutics, Inc. | 0.96% | $1.75M |
| Apogee Therapeutics, Inc. | 0.91% | $1.67M |
| Scholar Rock Holding Corp. | 0.89% | $1.62M |
| Praxis Precision Medicines, Inc. | 0.88% | $1.61M |
| Exelixis, Inc. | 0.88% | $1.60M |
| Mirum Pharmaceuticals, Inc. | 0.87% | $1.59M |
| United Therapeutics Corp. | 0.86% | $1.58M |
| Natera, Inc. | 0.86% | $1.58M |
| Celcuity, Inc. | 0.86% | $1.58M |
| Crispr Therapeutics AG | 0.86% | $1.58M |
| Krystal Biotech, Inc. | 0.85% | $1.55M |
| Protagonist Therapeutics, Inc. | 0.84% | $1.54M |
| Neurocrine Biosciences, Inc. | 0.84% | $1.53M |
| Incyte Corp. | 0.83% | $1.51M |
| Cg Oncology, Inc. | 0.83% | $1.51M |
| Cytokinetics, Inc. | 0.83% | $1.51M |
| Nuvalent, Inc. | 0.82% | $1.51M |
| Ionis Pharmaceuticals, Inc. | 0.82% | $1.50M |
| Bridgebio Pharma, Inc. | 0.82% | $1.50M |
| Vaxcyte, Inc. | 0.82% | $1.49M |
| Kymera Therapeutics, Inc. | 0.82% | $1.49M |
| Biogen, Inc. | 0.82% | $1.49M |
| Cogent Biosciences, Inc. | 0.82% | $1.49M |
| Ptc Therapeutics, Inc. | 0.82% | $1.49M |
| Insmed, Inc. | 0.80% | $1.47M |
| Alnylam Pharmaceuticals, Inc. | 0.79% | $1.45M |
| Roivant Sciences Ltd. | 0.79% | $1.45M |
| Halozyme Therapeutics, Inc. | 0.79% | $1.44M |
| Arcutis Biotherapeutics, Inc. | 0.78% | $1.42M |
| Spyre Therapeutics, Inc. | 0.77% | $1.41M |
| Soleno Therapeutics, Inc. | 0.77% | $1.40M |
| Abbvie, Inc. | 0.76% | $1.39M |
| Amgen, Inc. | 0.75% | $1.38M |
| Regeneron Pharmaceuticals, Inc. | 0.75% | $1.37M |
| Ultragenyx Pharmaceutical, Inc. | 0.75% | $1.36M |
| Acadia Pharmaceuticals, Inc. | 0.74% | $1.36M |
| Rhythm Pharmaceuticals, Inc. | 0.74% | $1.36M |
| Gilead Sciences, Inc. | 0.74% | $1.35M |
| Biomarin Pharmaceutical, Inc. | 0.74% | $1.34M |
| Viking Therapeutics, Inc. | 0.72% | $1.31M |
| Vertex Pharmaceuticals, Inc. | 0.71% | $1.30M |
| Immunitybio, Inc. | 0.71% | $1.29M |
| Immunovant, Inc. | 0.68% | $1.24M |
| Moderna, Inc. | 0.68% | $1.23M |
| Vera Therapeutics, Inc. | 0.66% | $1.21M |
| Immunome, Inc. | 0.65% | $1.19M |
| Disc Medicine, Inc. | 0.65% | $1.18M |
| Veracyte, Inc. | 0.63% | $1.14M |
| Sarepta Therapeutics, Inc. | 0.62% | $1.13M |
| Catalyst Pharmaceuticals, Inc. | 0.62% | $1.13M |
| Biocryst Pharmaceuticals, Inc. | 0.59% | $1.08M |
| Dyne Therapeutics, Inc. | 0.59% | $1.07M |
| Kodiak Sciences, Inc. | 0.57% | $1.04M |
| Recursion Pharmaceuticals, Inc. | 0.56% | $1.03M |
| Grail, Inc. | 0.55% | $1.01M |
| Arcus Biosciences, Inc. | 0.54% | $977.98K |
| Agios Pharmaceuticals, Inc. | 0.52% | $958.27K |
| Denali Therapeutics, Inc. | 0.51% | $939.65K |
| Oruka Therapeutics, Inc. | 0.51% | $922.58K |
| Dianthus Therapeutics, Inc. | 0.50% | $913.12K |
| Intellia Therapeutics, Inc. | 0.49% | $896.97K |
| Erasca, Inc. | 0.49% | $893.87K |
| Adma Biologics, Inc. | 0.49% | $893.54K |
| Syndax Pharmaceuticals, Inc. | 0.49% | $890.35K |
| Ardelyx, Inc. | 0.47% | $860.00K |
| Ideaya Biosciences, Inc. | 0.46% | $840.29K |
| Mineralys Therapeutics, Inc. | 0.46% | $837.66K |
| Nurix Therapeutics, Inc. | 0.46% | $831.79K |
| Tango Therapeutics, Inc. | 0.41% | $755.90K |
| Celldex Therapeutics, Inc. | 0.39% | $712.48K |
| Capricor Therapeutics, Inc. | 0.38% | $697.49K |
| Vericel Corp. | 0.38% | $687.13K |
| Inhibrx Biosciences, Inc. | 0.37% | $678.48K |
| Monte Rosa Therapeutics, Inc. | 0.37% | $667.38K |
| Novavax, Inc. | 0.36% | $655.79K |
| Biohaven Ltd. | 0.36% | $653.43K |
| Stoke Therapeutics, Inc. | 0.36% | $652.86K |
| Relay Therapeutics, Inc. | 0.36% | $650.24K |
| Taysha Gene Therapies, Inc. | 0.35% | $638.37K |
| Viridian Therapeutics, Inc. | 0.35% | $637.54K |
| Olema Pharmaceuticals, Inc. | 0.35% | $631.32K |
| Palvella Therapeutics, Inc. | 0.34% | $623.64K |
| Uniqure NV | 0.33% | $599.94K |
| Anaptysbio, Inc. | 0.33% | $596.57K |
| Corvus Pharmaceuticals, Inc. | 0.31% | $569.79K |
| Mannkind Corp. | 0.30% | $548.21K |
| Caredx, Inc. | 0.30% | $545.78K |
| Kalvista Pharmaceuticals, Inc. | 0.28% | $508.83K |
| Iovance Biotherapeutics, Inc. | 0.27% | $484.64K |
| Vir Biotechnology, Inc. | 0.25% | $457.37K |
| Geron Corp. | 0.25% | $453.28K |
| Precigen, Inc. | 0.24% | $442.35K |
| Sellas Life Sciences Group, Inc. | 0.23% | $411.28K |
| Tyra Biosciences, Inc. | 0.22% | $403.48K |
| Absci Corp. | 0.22% | $399.32K |
| Annexon, Inc. | 0.22% | $397.46K |
| Kura Oncology, Inc. | 0.22% | $394.60K |
| Sana Biotechnology, Inc. | 0.21% | $387.50K |
| Arrivent Biopharma, Inc. | 0.21% | $385.80K |
| Oric Pharmaceuticals, Inc. | 0.21% | $380.06K |
| Rigel Pharmaceuticals, Inc. | 0.20% | $362.72K |
| Janux Therapeutics, Inc. | 0.20% | $362.51K |
| Cytomx Therapeutics, Inc. | 0.18% | $337.13K |
| Savara, Inc. | 0.18% | $329.82K |
| Ars Pharmaceuticals, Inc. | 0.18% | $323.67K |
| Zenas Biopharma, Inc. | 0.17% | $310.01K |
| Cullinan Therapeutics, Inc. | 0.17% | $302.06K |
| Xencor, Inc. | 0.16% | $300.36K |
| Ironwood Pharmaceuticals, Inc. | 0.16% | $297.66K |
| Sionna Therapeutics, Inc. | 0.16% | $285.37K |
| Bicara Therapeutics, Inc. | 0.15% | $273.18K |
| Hyperliquid Strategies, Inc. | 0.15% | $266.27K |
| Prime Medicine, Inc. | 0.14% | $254.58K |
| Vor Biopharma, Inc. | 0.13% | $241.09K |
| Emergent Biosolutions, Inc. | 0.13% | $233.58K |
| Regenxbio, Inc. | 0.12% | $220.74K |
| Vanda Pharmaceuticals, Inc. | 0.12% | $218.30K |
| First Tracks Biotherapeutics, Inc. | 0.12% | $211.20K |
| 4d Molecular Therapeutics, Inc. | 0.12% | $210.96K |
| Allogene Therapeutics, Inc. | 0.11% | $200.33K |
| Altimmune, Inc. | 0.11% | $200.30K |
| Verastem, Inc. | 0.11% | $198.47K |
| Prothena Corp. PLC | 0.11% | $196.25K |
| Lexeo Therapeutics, Inc. | 0.10% | $191.41K |
| Myriad Genetics, Inc. | 0.10% | $185.15K |
| Arbutus Biopharma Corp. | 0.09% | $171.88K |
| Rocket Pharmaceuticals, Inc. | 0.09% | $163.70K |
| Ocugen, Inc. | 0.09% | $163.03K |
| Anavex Life Sciences Corp. | 0.09% | $159.94K |
| Akebia Therapeutics, Inc. | 0.08% | $150.37K |
| Invivyd, Inc. | 0.08% | $142.84K |
| Mimedx Group, Inc. | 0.08% | $138.39K |
| Perspective Therapeutics, Inc. | 0.07% | $120.58K |
| Compass Therapeutics, Inc. | 0.06% | $115.49K |
| Replimune Group, Inc. | 0.06% | $101.43K |
| Damora Therapeutics, Inc. | 0.02% | $43.44K |
BIPIX overview: performance, fees, allocation and SEC filings